Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-1040b in thrombectomy treated acute ischemic stroke
NCT03198715Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of DS1040b in ischemic stroke (5 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Intracranial Hemorrhage at 36 hours and Non-ICH Major Bleeding at 96 hours. Started Jul 2017; status: completed.
02
Drugs
DS1040b
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03198715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03198715.